
Malarone Tablets
250mg
Tablet · Prescription medication · Combination
GlaxoSmithKline Co., Ltd.
Atovaquone is an antiparasitic agent used for the prevention and treatment of malaria.
MFDS ingredient code M095955
Atovaquone is a drug belonging to the antiparasitic category, primarily used for the prevention and treatment of malaria. This ingredient inhibits the reproduction of the malaria parasite, preventing infection.
Atovaquone disrupts the mitochondrial function of the malaria parasite, hindering energy production. This prevents or treats infection by stopping the growth and reproduction of the parasite.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other antimalarials, atovaquone acts by targeting the mitochondria. As a result, the risk of developing resistance is relatively low, and it can enhance effectiveness when used in combination with other drugs.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.